Skip to content
healthcare.dev

Olumiant

NDC 0002-4479, baricitinib, tablet, film coated, from Eli Lilly and Company.

Product NDC
0002-4479
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207924
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4479 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BARICITINIB4 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0002-4479-300000244793030 TABLET, FILM COATED in 1 BOTTLE (0002-4479-30)
0002-4479-610000244796130 TABLET, FILM COATED in 1 BOTTLE (0002-4479-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/866e9f35-9035-4581-a4b1-75a621ab55cf
  • NADAC price for package 00002447930

    GET /v1/drugs/nadac/00002447930

Use it

Look up 0002-4479 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-4479 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-4479. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.